Ivabradine Tablet, Film Coated
Product Images NDC 69452-191

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ivabradine (NDC 69452-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Figure0002)

A line chart showing the proportion of patients with heart failure hospitalization or cardiovascular death over time in months from randomization. Two lines compare outcomes for placebo and ivabradine groups, with ivabradine consistently showing a lower proportion. Subject numbers at risk are listed below the graph for both groups at multiple time points.*

FDA Label Image

Figure 4 (Figure0003)

A forest plot chart showing hazard ratios (HR) with 95% confidence intervals (CI) comparing ivabradine versus placebo across various patient subgroups. The subgroups include age, sex, race, cause of heart failure, weight quartile, baseline heart rate quartile, NYHA class, baseline LVEF quartile, baseline beta blocker use quartile, baseline aldosterone antagonist use, diabetes history, and hypertension history. The horizontal axis ranges from 0.25 to 1.25, with markers indicating subgroup effects favoring either ivabradine or placebo.*

FDA Label Image

Figure 2 (Figure001)

A chart displaying changes in pharmacokinetic measures (Cmax and AUC) and corresponding 90% confidence intervals for ivabradine when combined with various drugs. It categorizes interactions by strong and moderate CYP3A4 inhibitors, CYP3A4 inducers, and others, with recommendations such as contraindicated, avoid use, or no dose adjustment. The x-axis shows fold change relative to ivabradine alone.*

FDA Label Image

5 mg 60's Label (Image001)

Label for ivabradine Tablets 5 mg film-coated oral tablets by Bionpharma Inc. The label includes the NDC number 69452-190-17, a warning for pharmacists to dispensed accompanying medication guides, quantity of 60 tablets, and storage instructions. The label also notes the dosage per tablet and states the product is Made in India.*

FDA Label Image

5 mg 500's Label (Image002)

Ivabradine Tablets 5 mg film-coated tablet label from Bionpharma Inc. The label states the product contains 500 tablets and includes dosage details, storage instructions, and manufacturer information. The label also features the NDC 69452-190-30 and barcodes for product identification.*

FDA Label Image

7.5 mg 60's Label (Image003)

Ivabradine Tablets 7.5 mg film-coated tablets label from Bionpharma Inc. It includes drug quantity of 60 film-coated tablets, with the strength prominently displayed as 7.5 mg. The label provides usage instructions, child-resistant packaging info, storage conditions, and distributor address in Princeton, NJ. The label also features a barcode, QR code, and manufacturing and lot details.*

FDA Label Image

7.5 mg 500's Label (Image004)

Ivabradine Tablets 7.5 mg film-coated oral tablets label. The label indicates a package of 500 tablets, distributed by Bionpharma Inc., Princeton NJ. The label includes dosage form, strength, storage instructions, barcode, and regulatory information. Made in India.*

FDA Label Image

Structure (Structure)

Chemical structure of ivabradine hydrochloride, depicting its molecular framework with two methoxy-substituted aromatic rings and a nitrogen-containing bicyclic system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.